TRAVERE THERAPEUTICS, INC.: revenue
| Value | {"amount": 212018000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | superseded |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/934b0b4f-d362-4662-b8f1-9676ea036ed7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-23-000008Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/revenue/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/934b0b4f-d362-4662-b8f1-9676ea036ed7
History
- no predecessors — first report